| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10053043 | The Journal of Urology | 2005 | 4 Pages |
Abstract
At a median of 19 months of TRT hypogonadal patients with a history of prostate cancer had no PSA recurrence and had statistically significant improvements in TT and hypogonadal symptoms. In highly select patients after RRP TRT can be administered carefully and with benefit to hypogonadal patients with prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
PIYUSH K. AGARWAL, MICHAEL G. OEFELEIN,